Projects per year
Fingerprint
Dive into the research topics where Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Peter Cole
- Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology - PROF-TE-DIV CHIEF
Person
-
Richard Drachtman
- Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology - PROF-CLIN-DIV CHIEF
Person
-
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL
Cole, P., Sands, S. A., Sands, S. A. & Sands, S. A.
9/17/18 → 8/31/22
Project: Research project
-
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia
Cole, P., SUSSMAN, E. & WAGSHUL, M.
3/1/21 → 2/28/22
Project: Research project
-
The multifaceted role of the Fanconi anemia tumor suppressor pathway in facilitating DNA replication
National Heart, Lung, and Blood Institute
9/1/18 → 8/31/20
Project: Research project
Research output
-
Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate
Wen, J., Patel, C., Diglio, F., Baker, K., Marshall, G., Li, S. & Cole, P. D., Mar 15 2022, In: Neuropharmacology. 206, 108939.Research output: Contribution to journal › Article › peer-review
-
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group
Buhtoiarov, I. N., Mba, N. I., Santos, C. D. L., McCarten, K. M., Metzger, M. L., Pei, Q., Bush, R., Baker, K., Kelly, K. M. & Cole, P. D., Jun 2022, In: Pediatric Blood and Cancer. 69, 6, e29649.Research output: Contribution to journal › Article › peer-review
-
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group
Parikh, R. R., Kelly, K. M., Hodgson, D. C., Hoppe, B. S., McCarten, K. M., Karolczuk, K., Pei, Q., Wu, Y., Cho, S. Y., Schwartz, C., Cole, P. D. & Roberts, K., Mar 15 2022, In: International Journal of Radiation Oncology Biology Physics. 112, 4, p. 890-900 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations